Full-Time

HIT Primary Care – Team Lead

Confirmed live in the last 24 hours

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Social Impact
Biotechnology
Healthcare

Compensation Overview

$219.8k - $366.4kAnnually

+ Bonus + Share-based Long Term Incentive Program

Senior, Expert

Remote in USA

The role can be virtual if near a major airport.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary

You match the following Pfizer's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • 5+ years of people and team leadership
  • 15+ years of Advanced Market and/or HIT Functional experience preferred
  • Customer / client facing experience
  • Ability to work effectively in a matrix organization and lead with indirect authority
  • Strong written and verbal communication influencing skills
  • Demonstrated ability to partner cross functionally to advance innovative solutions
  • Experience working with or within a leading health system to define, evolve and deliver functional and clinical strategy and population health approach
  • Understanding of trends in healthcare and aware of knowledge of US healthcare dynamics, with a deep understanding of HIT insights relative to these dynamics
  • Ability to influence key stakeholders at senior levels internally and externally (C-Suite LHS Executive, Presidents, BU & Medical Leaders, Department leaders, and Functional counterparts)
  • Advanced degree with experience across multiple relevant therapeutic areas
  • Demonstration of strong strategic thinking skills, as evidenced by the ability to identify alternative scenarios, resulting implications, and development of pragmatic recommendations
  • Ability to understand and translate market and competitive dynamics into strategic implications for Pfizer's business through the lens of HIT with preferred experience deploying innovative tools
Responsibilities
  • Lead Pfizer Primary Care LHS HIT efforts and lead a team of 6 HIT Account Directors and 1 HIT National Account Director aligned to Primary Care Key Account Management
  • Develop and execute an LHS HIT roadmap for the Pfizer Primary Care to identify, confirm and take advantage of prioritized opportunities
  • Work as a HIT subject matter expert to align across Business Units, cross-functionally and with the core teams to research, develop, manage, and evaluate multiple in-market engagements and projects
  • Provide HIT strategic direction, oversight and development for the personnel in the HIT functions
  • Lead both Enterprise and IM BU specific efforts to deliver innovative customer solutions that support standardized clinical integration and drive outcomes from a brand, leadership and market growth perspective
  • Ensure seamless leadership, alignment and partnership with needed cross-functional stakeholders (e.g., medical, digital and legal) during development and execution of efforts
  • Ensure HIT strategies, tactics and approach align with defined team goals and legal/compliance standards
  • Provide leadership and drive alignment for HIT related strategies and programs through Pfizer review committees
  • Maximize performance, customer engagement, and execution by coaching and developing self and direct reports to maximize customer impact
  • Lead the team to define needs (i.e. training, resources), uncover insights and develop strategies and tactics in a consultative way aligned with defined objectives
  • Engage customers and effectively model desired skills and behaviors to ensure appropriate situational coaching
  • Create an innovative and engaging work environment, providing clear direction, prioritization, guidance and feedback to the team
  • Set challenging performance objectives, provide performance coaching and demonstrate interest and support of employee’s career aspirations
Desired Qualifications
  • 15+ years of Advanced Market and/or HIT Functional experience preferred

Pfizer is a biopharmaceutical company that focuses on creating and manufacturing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then commercialized and sold to various clients such as governments, healthcare providers, and patients. Pfizer's products include vaccines, oncology treatments, and specialized medicines, with a notable contribution to the COVID-19 pandemic through its partnership with BioNTech to develop a widely used vaccine. What sets Pfizer apart from its competitors is its strong commitment to public health, exemplified by initiatives to provide vaccines to underserved populations and a continuous effort to expand its product portfolio with new approvals. The company's goal is to improve global health by ensuring access to effective treatments and vaccines.

Company Size

10,001+

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Starboard Value's $1 billion stake may drive strategic changes and increase shareholder value.
  • Pfizer's investment in fibrosis treatments expands its therapeutic areas.
  • Involvement in protein modification research diversifies Pfizer's treatment offerings.

What critics are saying

  • Slowdown in COVID-19 vaccine demand impacts Pfizer's revenue streams.
  • Activist investor Starboard Value may influence Pfizer's strategic decisions.
  • Emerging biotech companies pose a threat to Pfizer's market share in immunotherapy.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing predictive insights for drug development.
  • Pfizer's oncology portfolio is strengthened by investments in TCR-based immunotherapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

Business Wire
Jul 18th, 2024
CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts

CytoReason, a leader in developing computational disease models for predictive insights, announced today it secured an aggregated $80 million from Our